Establishment and Significance of Bioequivalence Recommendations for Individual Products-Drugs Acting on Circulatory System and Others |
Bae, Soo Hyeon
(College of Pharmacy, The Catholic University of Korea)
Zheng, Yu Fen (Department of Clinical Pharmacy, College of Pharmacy, Seoul National University) Kwon, Min Jo (College of Pharmacy, The Catholic University of Korea) Choi, Eu Jin (College of Pharmacy, The Catholic University of Korea) Bae, Soo Kyung (College of Pharmacy, The Catholic University of Korea) |
1 | European public assessment reports. EMEA. http://www.ema.europa.eu/ema [Online] (last visited on 28 May 2013). |
2 | Drug Approval Report. KFDA, 2011. (Korean) |
3 | KFDA Guideline for the Validation of Bioanalytical Method. http://drug.kfda.go.kr [Online] (last visited on 28 May 2013). |
4 | Guidance for industry: Bioequivalence recommendations for specific products. US FDA, 2010. http://www.fda.gov/Drugs/Guidance ComplianceRegulatoryInformation/Guidances/ default.htm [Online] (last visited on 28 May 2013). |
5 | www.clinicaltrials.gov [Online] (last visited on 28 May 2013). |
6 | Guideline for the Drug Equivalence Test (Notification No. 2001-71 of the KFDA, 2011. 11. 23). (Korean) |
7 | KFDA Online drug library. http://drug.kfda.go.kr [Online] (last visited on 28 May 2013). |